申请人:Bylund Johan
公开号:US20090163586A1
公开(公告)日:2009-06-25
The invention provides compounds of formula (I)
wherein R
1
, R
3
, L
1
, L
2
, G
1
, G
2
, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.
该发明提供了式(I)的化合物
其中R
1
,R
3
,L
1
,L
2
,G
1
,G
2
,A和m如规范中定义的那样,以及其光学异构体,消旋体和互变异构体,以及其药学上可接受的盐;以及它们的制备方法,含有它们的药物组合物以及它们在治疗中的应用。这些化合物是微粒体前列腺素E合成酶-1的抑制剂。